SILVERARC CAPITAL MANAGEMENT, LLC

Q3 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
9/30/2026
Date filed
11/12/2026
Form type
13F-HR
Num holdings
70
Total value ($000)
$854,444
Net value change ($000)
-107,710 (-11.2%)
New positions
15
Sold out positions
16
Turnover %
21.6%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/13/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KOD 49,834 234.2%
CLDX 15,803 NEW
BIIB 15,084 145.1%
SGMT 14,379 63.5%
CELC 11,456 21.9%
GLUE 10,314 38.5%
RAINIER ACQUISITION CORP 8,710 NEW
SYRE 8,134 152.8%
YARROW BIOSCIENCE INC 6,799 NEW
OVID 6,474 77.6%
Top Reduces (Value $000, Stocks/ETFs)
SNDX -21,896 -82.5%
Ascendis Pharma AS -20,337 -37.0%
ELVN -19,269 -77.6%
VCYT -18,676 -100.0%
DNTH -17,186 -45.2%
PRAX -16,236 -73.8%
GH -14,977 -100.0%
ORKA -12,927 -38.5%
TRVI -12,646 -100.0%
MANE -11,679 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 33,495 (3.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type